Relmada Therapeutics, Inc. RLMD Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s total current assets?
- Relmada Therapeutics, Inc. (RLMD) reported total current assets of $235.34M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s total current assets changed year-over-year?
- Relmada Therapeutics, Inc.'s total current assets increased by 750.9% year-over-year, from $27.66M to $235.34M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s total current assets has grown at a -4.5% compound annual growth rate (CAGR), from $118.07M to $93.98M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.